Neogen Corporation Could Re-Rate As 3M Food Safety Integration Improves

Neogen Corporation's sizeable $11 billion food-and-animal safety TAM still has secular tailwinds with regulation, traceability, and disease-prevention trends. Management believes this market has an overall projected 6%–7% CAGR through 2030. In that context, NEOG's Petrifilm anchors future recurring consumables and end-to-end testing ecosystem.

Seeking Alpha • Feb 16, 2026

Animal Health Firm Neogen Initiates Recall Of Vials Over Microbial Contamination

Neogen Corporation (NASDAQ: NEOG) on Wednesday initiated a voluntary nationwide recall of all unexpired lots of its Neogen Vet HYCOAT Hyaluronate Sodium Sterile Solution. The company identified microbial contamination in certain batches.

Benzinga • Jan 29, 2026

Neogen Issues Voluntary Nationwide Recall of Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution

LANSING, Mich.--(BUSINESS WIRE)--Neogen Corporation (NASDAQ: NEOG) is voluntarily recalling all lots within expiry of Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution, for use in dogs, cats, and horses, to the veterinarian level. Neogen distributes this product, which is manufactured by a third-party supplier. This recall has been initiated due to microbial contamination in certain lots of 10 mL/50 mg product vials. Neogen received a number of reports of adverse events in horses following.

Business Wire • Jan 28, 2026

Neogen Corporation (NEOG) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Neogen Corporation (NEOG) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Seeking Alpha • Jan 15, 2026

Neogen's Q2 Earnings and Revenues Beat Estimates, Stock Climbs

NEOG's Q2 EPS and revenues top estimates, sending shares up 31.6% as the company raises its fiscal 2026 revenue and EBITDA outlook.

Zacks Investment Research • Jan 12, 2026

Why Neogen Stock Blasted More Than 31% Higher Today

The specialized healthcare company posted a beat-and-raise fiscal second quarter. Investors rushed into the stock, despite the fact that revenue and profitability were both down slightly year-over-year.

The Motley Fool • Jan 9, 2026

Neogen Soars After Earnings Beat and Raised Outlook

Neogen beat earnings estimates, raised its full-year revenue outlook, and has now posted back-to-back post-earnings stock spikes.

Barrons • Jan 8, 2026

Neogen Corporation (NEOG) Q2 2026 Earnings Call Transcript

Neogen Corporation (NEOG) Q2 2026 Earnings Call Transcript

Seeking Alpha • Jan 8, 2026

Neogen Announces Second-Quarter 2026 Results

LANSING, Mich.--(BUSINESS WIRE)--Neogen Corporation (NASDAQ: NEOG) announced today the results of the second quarter ended November 30, 2025. “I am exceptionally proud of the Neogen team as we have initiated the first phase of our strategic transformation with early work focused on stabilizing and strengthening our core business. While it is early in the process, and our industry is currently seeing macro headwinds, our team drove significant sequential improvement in core revenue growth and pr.

Business Wire • Jan 8, 2026

Neogen's Raised Outlook Fuels Turnaround Hopes, Stock Soars

Neogen Corp. (NASDAQ: NEOG) stock rose after the company reported better-than-expected second-quarter financial results.

Benzinga • Jan 8, 2026